Dosidal · Canada

TEVA-LEVOFLOXACIN

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketCanada
Recordca:authorisation:din:02315440:80098 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersca-din: 02315440
ca-dpd-drug-code: 80098
Source authorityHealth Canada
Read date2026-11-15T06:54:55Z
authorisation statuslifecycle: current
status: MARKETED
status_date: 2025-10-16
status_date_as_published: 16-OCT-2025
status_history: date: 2014-08-01
status: APPROVED; date: 2014-08-02
status: MARKETED; date: 2014-07-04
status: APPROVED; date: 2017-08-16
status: APPROVED; date: 2017-08-16
status: MARKETED; date: 2017-08-16
status: APPROVED; date: 2025-10-16
status: APPROVED; date: 2025-10-16
status: APPROVED; date: 2025-10-16
status: MARKETED; date: 2009-06-24
status: MARKETED; date: 2009-06-24
status: APPROVED
state: current · read 2026-11-15T06:54:55Z · source: Health Canada - Drug Product Database page
controlled statuscontrolled: False
state: current · read 2026-11-15T06:54:55Z · source: Health Canada - Drug Product Database page
identityatc: J01MA12
brand_name: TEVA-LEVOFLOXACIN
class: Human
companies: TEVA CANADA LIMITED
din: 02315440
drug_code: 80098
extract_set: marketed
forms: TABLET
ingredients: ingredient: LEVOFLOXACIN (LEVOFLOXACIN HEMIHYDRATE)
strength: 750 MG
packaging_as_published: product_information: 50
routes: ORAL
state: current · read 2026-11-15T06:54:55Z · source: Health Canada - Drug Product Database page
prescription classclass: prescription
schedules: PRESCRIPTION
state: current · read 2026-11-15T06:54:55Z · source: Health Canada - Drug Product Database page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
pvKTfmYH-_VNS5do_Bkj_5E7YvnpRzB4uCZFRT0q0p0zIMYq7jkY8tN3tJgvcrT9T-SMOYeDvu5A5qMqVKTMXw
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ca:authorisation:din:02315440:80098 · Same medicine in other markets · Dosidal